NCT00752232 - Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Alzheimer Disease

Interventions

BIOLOGICAL

ACC-001

IM injection, dose of 3, 10, 30 micrograms, Day 1, month 3, 6, 9, 12

OTHER

QS-21

IM injection, dose of 50 micrograms, Day 1, month 3, 6, 9, 12

BIOLOGICAL

ACC-001

IM injection, dose of 3, 10, 30 micrograms, Day 1, month 3, 6, 9, 12

OTHER

QS-21

IM injection, dose of 50 micrograms, Day 1, month 3, 6, 9, 12

OTHER

PBS

IM injection, Day 1, month 3, 6, 9, 12

Trial Locations (10)

Suwa Red Cross Hospital, Suwa

Tazuke Kofukai Medical Research Institute Kitano Hospital, Osaka

Osaka Medical College Hospital, Takatsuki

Meitetsu Hospital, Aichi

Ibaraki Prefectural Central Hospital, Ibaraki

Shonan Atsugi Hospital, Kanagawa

Kitasato University East Hospital, Kanagawa

Juntendo University Hospital, Tokyo

Juntendo Tokyo Koto Geriatric Medical Center, Tokyo

Kanto Ctrl Hp of the Mutual Aid Asso of Public school Teache, Tokyo